SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 77.20 |
| Enterprise Value ($M) | 156.91 |
| Book Value ($M) | -92.48 |
| Book Value / Share | -1.47 |
| Price / Book | -0.83 |
| NCAV ($M) | -92.79 |
| NCAV / Share | -1.48 |
| Price / NCAV | -0.83 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -3.72 |
| Return on Assets (ROA) | -1.60 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.13 |
| Current Ratio | 1.13 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 28.67 |
| Assets | 28.97 |
| Liabilities | 121.45 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 47,709 | 132,761 | 35.94 | |
| 88,254 | 255,678 | 34.52 | |
| 43,305 | 175,583 | 24.66 | |
| 160,235 | 673,030 | 23.81 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| FENC – Fennec Pharmaceuticals Inc. | FLGC – Flora Growth Corp. |
| FTLF – FitLife Brands, Inc. | GDTC – CytoMed Therapeutics Limited |
| GELS – Gelteq Limited |